1. Eagan, R., Hahn, R., Myers, R.: Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.Cancer Treat. Rep., 60, 115 (1976).
2. Elomaa, I., Kellokumpu-Lehtinen, P., Rannikko, S., Alfthan, O.: Hormone-resistant metastatic prostate cancer. Comparisons between estramustine phosphate and lowdose epirubicin treatments.Eur. Urol., 19, 12 (1991).
3. Fergusson, J. F., Hendry, W. F.: Pituitary irradiation in advanced carcinoma of the prostate: Analysis of 100 cases.Br. J. Urol., 43, 514 (1971).
4. Huggins, C., Hodges, C. V.: Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.Cancer Res., 1, 293 (1941).
5. Japanese Urological Association & Japanese Pathological Society: General Rules for Clinical and Pathological Studies on Prostatic Cancer. Kanehara, Tokyo 1985.